Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in ...
Tuya COO &CFO Alex Yang discusses the company’s latest earnings, saying customers are looking to introduce more AI in the ...
MustGrow Biologics (TSXV:MGRO, OTCQB:MGROF) has reached its first development milestone under its collaboration with Bayer, ...
Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international ...
NuScale Power receives a speculative Buy rating at $9.44, with a five-year horizon focused on commercialization milestones.
<?xml encoding="utf-8" ?> McKesson Corporation MCK on Tuesday announced an agreement to acquire Precision Medicine Group. The ...
The strategic partnership supports Lundbeck's Focused Innovator strategy and bionic ambitions. By combining AI-powered ...
AFI Labs offers a single collaborative environment where customers can rapidly develop, validate, and scale new food ...
CHICAGO, Aug. 20, 2026 /PRNewswire/ -- EVERSANA, a leading provider of global commercialization services to the life sciences industry today announced expanded capabilities of their AI-powered ...
August Bioservices’ Ryan Downey discusses fill-finish capacity, Annex 1 readiness, technical expertise and the infrastructure ...
Daiichi Sankyo (TSE: 4568) has appointed Ken Keller to the newly created role of Chief Commercialization Officer, responsible ...
An illustration of a commercial space station based on a New Glenn upper stage, part of a summary submitted by Blue Origin, one of a dozen companies that performed LEO commercialization studies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results